Key Figures Q3 2002

Key Figures provides a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years, if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

• Q3 2002 operating profit EUR 104 million, up 8% from Q3 2001 on a comparable basis.
• Net profit in Q3 2002 EUR 88 million (Q3 2001: EUR 101 million, which still included DSM Petrochemicals and Energie Beheer Nederland).
• Intended acquisition of Roche’s Vitamins and Fine Chemicals division announced.
• Outlook: Fourth-quarter operating profit significantly higher than in Q4 2001 and operating profit for the whole of 2002 substantially higher than in 2001, on a comparable basis.